Harmony Biosciences Q4 Earnings Call Highlights

Looking ahead, the company reiterated guidance for 2026 WAKIX net revenue of $1.0 billion to $1.04 billion , which management characterized as achieving blockbuster status for the first time in franchise history. CFO Sandeep Kapadia cautioned that first-quarter 2026 revenue is expected to show typical industry seasonality, including higher gross-to-net deductions tied to insurance resets and higher copay obligations, along with potential trade inventory drawdowns.For the full year, Harmony reported $868.5 m ...